TCL Archive Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines. March 31, 2000
TCL Archive Appeals Court Finds Terminally Ill Patients Have Constitutional Right To Phase I Drugs. May 5, 2006
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014